• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Tolle leads WaveLight's U.S. operations as CEO

Article

Sterling, VA-Wolfgang Tolle has been appointed as the new chief executive officer (CEO) of U.S. operations for WaveLight Inc., a subsidiary of WaveLight AG. In his new post, Tolle will assume responsibility for all business activities at the U.S. based-subsidiary and will report to WaveLight AG's CEO Max Reindl.

Sterling, VA-Wolfgang Tolle has been appointed as the new chief executive officer (CEO) of U.S. operations for WaveLight Inc., a subsidiary of WaveLight AG. In his new post, Tolle will assume responsibility for all business activities at the U.S. based-subsidiary and will report to WaveLight AG's CEO Max Reindl.

Most recently, Tolle was CEO of Launchdreams, a company that specializes in helping international enterprises become established and grow in the United States.

In addition, Tolle has held numerous other executive positions, including CEO, vice president of customer service, and chief technology officer at Cyveillance; president of Virginia's Center for Innovative Technology; and as president of the U.S. office of the German National Research Center for Computer Science.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.